The ABC's 7:30 Report Features World-First Trial
Earlier this week, the ABC's 7:30 Report featured a clinical trial investigating the use of short-term, high dose, intravenous zinc as a mechanism of limiting pulmonary fibrosis in patients with COVID-19. Joseph Ischia was interviewed regarding the trial.
"This work, with regard to renal ischaemia, has been presented at multiple USANZ meetings", said Damien Bolton, who is collaborating with Joseph Ischia to coordinate the trial. He added, the coverage represented "a great step in regards to the legitimacy of our urologist led clinical trial, that is recruiting strongly and progressing very well".